- Lexicon Pharmaceuticals (NASDAQ:LXRX) Monday filed a prospectus related to the proposed resale of 57.66M shares by selling stockholders.
- This prospectus is not an offer to sell these securities.
- SEC Filing.
More on Lexicon Pharmaceuticals
- Lexicon Pharmaceuticals: Moving To Maximize The Value Of Its Core Asset
- Lexicon Pharmaceuticals Putting The Pieces Together, But Much Is Left To Do
- Lexicon Pharma: Inpefa's Early Clinical Benefits, Rehospitalization Data May Unlock Significant Value
- Lexicon stock slides 8% after rallying 30% in prior session
- Lexicon stock rallies 18% amid FDA update, $250M private placement